EMA Authorised: Dukoral (recombinant cholera toxin B subunit;vibrio cholerae 01) — Valneva Sweden AB

View source ↗

Summary

EMA authorised Dukoral, a cholera vaccine based on recombinant cholera toxin B subunit, for immunization against cholera.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Dukoral (Cholera vaccine (inactivated whole-cell with recombinant B subunit))

Snippet

Status: Authorised. Therapeutic area: Cholera;Immunization. MAH: Valneva Sweden AB. Decision date: 07/01/2021